you are here:
Success
Alert
Please select a Day.
Info
942.00
-2.20 (-0.23%)

As on 07 May, 2021 | 03:59

Trade
Day Range
941.10
954.60
L H
52 Week Range
555.10
996.00
L H
Volume
206,097
*
i

* BSE Market Depth (07 May 2021)

BUY SELL
QTY PRICE PRICE QTY
5 940.05 945.00 268
10 940.00 945.10 5
1 937.00 945.80 150
70 936.30 946.00 132
24 935.00 947.50 5
4466 Total Total 9576
Bid / Ask
940.05 / 941.55
941.55
-2.70 (-0.29%)

As on 07 May, 2021 | 04:00

Day Range
922.65
953.00
L H
52 Week Range
556.50
995.05
L H
Volume
22,006
*
i

* BSE Market Depth (07 May 2021)

BUY SELL
QTY PRICE PRICE QTY
5 940.05 945.00 268
10 940.00 945.10 5
1 937.00 945.80 150
70 936.30 946.00 132
24 935.00 947.50 5
4466 Total Total 9576
Bid / Ask
940.05 / 941.55
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open954.00
          Previous Close944.20
          UC Limit1,133.00
          LC Limit755.40
          Volume206,097.00
          VWAP944.83
          Mkt Cap (Rs. Cr.)17,176
          20D Avg Volume588,195
          20D Avg Delivery238,630
          Beta0.250.19
          Face Value2.00
          TTM EPS26.43
          TTM PE35.64
          Sector PE41.59
          Book Value Per Share207.57
          P/B4.54
          Dividend Yield0.72
          P/C29.52

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Mid range performer: Stock with medium financial performance with average price momentum and valuation. These stocks may be affordable and are showing some investors interest.

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 69.7% away from 52 week low
          • 5.42% away from 52 week high
          • Outperformer - Natco Pharma up by 11.29% v/s NIFTY 50 up by 0.03% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          4

          indicates Weak Financials

          3 year CAGR growth
          Revenue -0.2%
          NetProfit -1.8%
          OperatingProfit -5.2%
          Industry Comparison
          • TTM PE Ratio - Above industry Median
          • Market Cap - High in industry
          • Price to Book Ratio - Above industry Median
          • TTM PEG Ratio - Negative PEG TTM Price to Earnings Growth
          Shareholding Pattern
          • Promoters have decreased holdings from 48.91% to 48.87% in Mar 2021 qtr
          • Mutual Funds have increased holdings from 8.92% to 9.45% in Mar 2021 qtr.
          • Number of MF schemes decreased from 55 to 49 in Mar 2021 qtr
          • FII/FPI have decreased holdings from 18.16% to 16.34% in Mar 2021 qtr
          • Number of FII/FPI investors decreased from 280 to 261 in Mar 2021 qtr
          • Institutional Investors have decreased holdings from 33.2% to 32.49% in Mar 2021 qtr

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Natco Pharma

          What's your call on Natco Pharma today?

          Read 3 investor views

          BUY SELL HOLD

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          05 Jul, 2019

          EAST BRIDGE CAPITAL MASTER FUND I LTD

          Qty 1577761 Price 528 % Traded 0.87
          28 Jun, 2017

          CX SECURITIES LIMITED

          Qty 1198400 Price 930.03 % Traded 0.66
          20 Jun, 2014

          MV SCIF MAURITIUS

          Qty 174903 Price 1149.56 % Traded 0.10
          29 Jul, 2013

          MERRILL LYNCH CAPITAL MARKET ESPANA SA SV

          Qty 199668 Price 589.55 % Traded 0.11
          17 Jun, 2013

          KOTAK INDIA VENTURE FUND I

          Qty 211810 Price 445 % Traded 0.12
          17 Jun, 2013

          KOTAK INDIA VENTURE FUND I

          Qty 159070 Price 445 % Traded 0.09
          17 Feb, 2012

          PASHA FINANCE PVT LTD

          Qty 200000 Price 278 % Traded 0.11
          17 Feb, 2012

          R K CHARI STOCK BROKING P LTD

          Qty 200000 Price 278 % Traded 0.11

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          Feb, 19, 2021

          KOMAL SUBHADRA MADINEEDI

          Immediate Relative
          Qty 7350 Price 0 % Traded 0.00 Post Tnx Hold. 0%
          Feb, 19, 2021

          SUSEELA PINNAMANENI

          Immediate Relative
          Qty 7350 Price 0 % Traded 0.00 Post Tnx Hold. 0%
          Feb, 09, 2021

          LAKSHMINARAYANA A

          Designated Person
          Qty 1850 Price 2 % Traded 0.00 Post Tnx Hold. 0.01%
          Feb, 09, 2021

          SADA SIVA RAO N

          Designated Person
          Qty 2100 Price 2 % Traded 0.00 Post Tnx Hold. 0.04%
          Jan, 13, 2021

          VENKATA SREENIVASABABU KURRA

          Designated Person
          Qty 2625 Price 2 % Traded 0.00 Post Tnx Hold. 0%
          Jan, 04, 2021

          PURANDHAR TUMMALA

          Employee
          Qty 4000 Price 9682.51 % Traded 0.00 Post Tnx Hold. 0.14%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Sep, 25, 2020

          Time Cap Pharma Labs Pvt Ltd

          Promoter
          Qty 18200 Price 0 % Traded 0.01 Post Tnx Hold. 9.43%
          Dec, 21, 2019

          Sau Family Trust

          Promoter
          Qty 1700 Price 0 % Traded 0.00 Post Tnx Hold. 0%
          Dec, 21, 2019

          VCN Family Pvt Trust

          Promoter
          Qty 1700 Price 0 % Traded 0.00 Post Tnx Hold. 0%
          Jul, 05, 2019

          Venkata Satya Swathi Kantamani

          Other
          Qty 12723340 Price 0 % Traded 7.00 Post Tnx Hold. 0%
          Jul, 01, 2019

          V C Nannapaneni

          Promoter
          Qty 12723340 Price 0 % Traded 7.00 Post Tnx Hold. 12.43%
          Jul, 01, 2019

          Venkata Satya Swathi Kantamani

          Promoter
          Qty 12723340 Price 0 % Traded 7.00 Post Tnx Hold. 8.79%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • Revenue
          • Net Profit
          • EPS

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Natco Pharma 942.00 -0.23 17176.22 35.64 4.54 12.21 52.66 458 1,915 0.08
          Sun Pharma 679.45 0.01 163022.81 63.62 3.32 8.31 50.25 4,186 32,837 0.17
          Divis Labs 4029.10 -0.84 106959.95 57.18 14.63 18.83 78.37 1,376 5,394 0.00
          Dr Reddys Labs 5174.70 0.12 86055.90 39.56 5.52 12.98 34.84 1,969 17,517 0.11
          Cipla 882.90 -0.16 71202.64 31.83 4.45 9.81 49.76 1,546 17,131 0.18

          About the Company

          Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million.It is an India-based company engaged in manufacturing active pharmaceutical ingredients.The Companys segments include bulk chemicals, finished dosage formulations, retail pharmacy and job work charges. The Companys products in the oncology segment include Desifer, Veenat, Bendit, Bortenat, Lenalid and Clokeran. The Companys product offerings in the pharma segment include T-Score, PT-MaX, Glatimer, Tarana and Tigi. The Company operates in India, United States of America, Europe and the rest of the world.
          {"success":1,"data":{"address":{"address1":"NATCO House,","address2":"Road # 2,,Banjara Hills,","city":"Hyderabad","state":"Telangana","pincode":"500034","telephone1":"040-23547532","telephone2":"","fax1":"040-23548243","fax2":"","email":"investors@natcopharma.co.in","web":"http:\/\/www.natcopharma.co.in"},"management":[{"name":"V C Nannapaneni","designation":"Chairman & Managing Director"},{"name":"Rajeev Nannapaneni","designation":"Vice Chairman & CEO"},{"name":"T V Rao","designation":"Independent Director"},{"name":"G S Murthy","designation":"Independent Director"},{"name":"D G Prasad","designation":"Independent Director"}],"registrars":{"name":"Venture Capital & Corporate Investments Pvt. Ltd.","address1":"No. 12-10-167,","address2":"Bharat Nagar","address3":"","address4":"","telephone":"040-23818475, 23818476, 23868023","fax":"040-23868024","email":"info@vccilindia.com","internet":"http:\/\/www.vccilindia.com","city":"Hyderabad","state":"Telangana","pincode":"500018"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"524816","nseId":"NATCOPHARM","series":"EQ","isinid":"INE987B01026"}}}
          • Registered Office

          • Registrars

          • Management

            • V C Nannapaneni

              Chairman & Managing Director

            • Rajeev Nannapaneni

              Vice Chairman & CEO

            • T V Rao

              Independent Director

            • G S Murthy

              Independent Director

            • D G Prasad

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

          • Details

            • BSE:

              524816

            • NSE:

              NATCOPHARM

            • Series

              EQ

            • ISIN

              INE987B01026

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>